Skip to content
Use caution Drug recall · FDA · Published September 9, 2015

Bravelle 75 IU Recall: Subpotent Drug Risk

Ferring Pharmaceuticals recalls Bravelle 75 IU vials due to subpotency. Check lot numbers K11813A-1 through L10992AA for this Class III drug recall.

🇺🇸 FDA recall #D-0015-2016DrugBravelle ›
Take action

Contact the company

Recalling firmFerring Pharmaceuticals Inc100 Interpace Pkwy · Parsippany, NJ 07054-1149
✎ GovInfoNow plain-language explainer

Ferring Pharmaceuticals Inc has recalled specific lots of Bravelle 75 IU (urofollitropin for injection) because the drug is subpotent. This means the medication may not contain enough active ingredient to be effective. The recall covers approximately 32,341 vials distributed nationwide. Read more at govinfonow.com/recall/43738-ferring-pharmaceuticals-inc-recalls-bravelle-75-iu-urofollitropin-for-injection.

Source Summary by GovInfoNow · govinfonow.com/recall/43738-ferring-pharmaceuticals-inc-recalls-bravelle-75-iu-urofollitropin-for-injection · Updated October 12, 2026 · FDA enforcement record: FDA #D-0015-2016

Cite this page

“Bravelle 75 IU Recall: Subpotent Drug Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43738-ferring-pharmaceuticals-inc-recalls-bravelle-75-iu-urofollitropin-for-injection. Based on FDA recall #D-0015-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0015-2016%22&limit=1).

The FDA announced on 2015-09-09 that Ferring Pharmaceuticals Inc is recalling Bravelle 75 IU Injection Vials due to subpotent drug risks. Owners should contact the company for a refund, according to the FDA.

How to tell if you have it

  • Brand: Bravelle
  • Product: Bravelle 75 IU (urofollitropin for injection, purified)
  • NDC: 55566-8505-6
  • Lot codes: K11813A-1, K11813A-2, Exp 01/16; K11813B-1, K11813C-1, Exp 04/16; K13031A-1, K13031B-1, K13031B-2, Exp 05/16; H14942A-1, H14941A-2, H18815A-1, H15815B-1, H15815SMA-1, H16998A-1, H16998SMA-1, K10008A-1, K10008A-2, K11813A-2, K11813B-1, K11813C-1, K13031A-1, K13031B-1, K13031B-2, K13503SMA-1, K13503A-1, K13503B-1, K13512A-1, K13512A-2, K1392A-1, K13921A-2, K13921B-1, K14616A-1, K14616A-2, K15917A-1, K15917SMA-1, K15917SMA-2, K17006AA, K18201AA, K18202AA, L10403AA, L10403AB, L10840AA, L10992AA
  • Distribution: Nationwide

The hazard

The recall is due to the product being subpotent, meaning it may not deliver the expected dosage. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Ferring Pharmaceuticals Inc has had 8 other recalls since 2012-08-23. Other recent recalls of similar products include Ferring Endometrin Vaginal Inserts Recall (2023-06-12), Ferring ZOMA-Jet 5 Kit May Break Apart - Stop Using Now (2021-03-11), and Ferring Menopur 75 IU Recall (2021-03-02). Other recent recalls of similar products include Unichem busPIRone 5mg Tablets Recall (2026-04-13), Gasco Isopropyl Alcohol 70% Recall (2026-05-29), and Specialty Process Labs Thyroid Product Recall (2026-01-16).

How to tell if you have this one

Check your vials for the brand name Bravelle 75 IU and NDC 55566-8505-6. Affected lots include K11813A-1, K11813A-2, K11813B-1, K11813C-1, K13031A-1, K13031B-1, K13031B-2, and additional lots such as H14942A-1, H14941A-2, H18815A-1, H15815B-1, H15815SMA-1, H16998A-1, H16998SMA-1, K10008A-1, K10008A-2, K13503SMA-1, K13503A-1, K13503B-1, K13512A-1, K13512A-2, K1392A-1, K13921A-2, K13921B-1, K14616A-1, K14616A-2, K15917A-1, K15917SMA-1, K15917SMA-2, K17006AA, K18201AA, K18202AA, L10403AA, L10403AB, L10840AA, and L10992AA.

  • Brand
    Bravelle
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Numbers

    Compare the lot numbers on your Bravelle vials against the list of recalled lots provided in the record.

  2. Contact Your Healthcare Provider

    If you have a recalled lot, consult your doctor or pharmacist immediately to discuss alternative treatment options.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 5.2 years after the firm started it.

1. Firm started the recall: Sep 9, 201512. FDA classified it Class III: Oct 14, 201523. Published in FDA’s Enforcement Report: Oct 21, 201534. FDA terminated the recall: Nov 18, 2020420152020
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0015-2016 (September 9, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0015-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA